These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose response to nitric oxide in adult cardiac surgery patients. Solina AR; Ginsberg SH; Papp D; Grubb WR; Scholz PM; Pantin EJ; Cody RP; Krause TJ J Clin Anesth; 2001 Jun; 13(4):281-6. PubMed ID: 11435053 [TBL] [Abstract][Full Text] [Related]
3. A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. Solina A; Papp D; Ginsberg S; Krause T; Grubb W; Scholz P; Pena LL; Cody R J Cardiothorac Vasc Anesth; 2000 Feb; 14(1):12-7. PubMed ID: 10698385 [TBL] [Abstract][Full Text] [Related]
4. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation. Fullerton DA; Jones SD; Jaggers J; Piedalue F; Grover FL; McIntyre RC J Thorac Cardiovasc Surg; 1996 Apr; 111(4):753-62; discussion 762-3. PubMed ID: 8614135 [TBL] [Abstract][Full Text] [Related]
5. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. Kieler-Jensen N; Lundin S; Ricksten SE J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728 [TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Rajek A; Pernerstorfer T; Kastner J; Mares P; Grabenwöger M; Sessler DI; Grubhofer G; Hiesmayr M Anesth Analg; 2000 Mar; 90(3):523-30. PubMed ID: 10702430 [TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy. Hayward CS; Kalnins WV; Rogers P; Feneley MP; Macdonald PS; Kelly RP J Cardiovasc Pharmacol; 1999 Nov; 34(5):749-54. PubMed ID: 10547093 [TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011 [TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Ardehali A; Hughes K; Sadeghi A; Esmailian F; Marelli D; Moriguchi J; Hamilton MA; Kobashigawa J; Laks H Transplantation; 2001 Aug; 72(4):638-41. PubMed ID: 11544423 [TBL] [Abstract][Full Text] [Related]
18. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD. Germann P; Ziesche R; Leitner C; Roeder G; Urak G; Zimpfer M; Sladen R Chest; 1998 Jul; 114(1):29-35. PubMed ID: 9674443 [TBL] [Abstract][Full Text] [Related]
19. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166 [TBL] [Abstract][Full Text] [Related]
20. A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation. Pagano D; Townend JN; Horton R; Smith C; Clutton-Brock T; Bonser RS Eur J Cardiothorac Surg; 1996; 10(12):1120-6. PubMed ID: 10369648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]